Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) Operating Margin (2024 - 2025)

Historic Operating Margin for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q2 2025 value amounting to 43981.65%.

  • Neuphoria Therapeutics' Operating Margin changed N/A to 43981.65% in Q2 2025 from the same period last year, while for Dec 2025 it was 23.83%, marking a year-over-year change of. This contributed to the annual value of 7.21% for FY2025, which is N/A changed from last year.
  • Neuphoria Therapeutics' Operating Margin amounted to 43981.65% in Q2 2025.
  • In the past 5 years, Neuphoria Therapeutics' Operating Margin ranged from a high of 43981.65% in Q2 2025 and a low of 558.84% during Q4 2024